| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oric Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 5.38M | $46.2M | $8.59 | Dec 23, 2022 | Direct |
| Pyxis Oncology, Inc. | 10%+ Owner | Common Stock, $0.001 par value per share | 5.95M | $16.4M | $2.76 | Mar 17, 2023 | Direct |
| Pyxis Oncology, Inc. | 10%+ Owner | Common Stock, $0.001 par value per share | 1.08M | $2.98M | $2.76 | Mar 17, 2023 | By Pfizer Ventures (US) LLC |
| Cerevel Therapeutics Holdings, Inc. | Former 10% Owner | Common Stock | 0 | $0 | $45.00 | Aug 1, 2024 | Direct |
| Zura Bio Ltd | 10%+ Owner | Class A Ordinary Shares, $0.0001 par value | 2.97M | Mar 20, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CERE | Cerevel Therapeutics Holdings, Inc. | Aug 1, 2024 | 1 | -$1.23B | 4 | Aug 5, 2024 | Former 10% Owner |
| ZURA | Zura Bio Ltd | Mar 20, 2023 | 0 | $0 | 3 | Mar 30, 2023 | 10%+ Owner |
| PYXS | Pyxis Oncology, Inc. | Mar 17, 2023 | 1 | $5M | 4/A | Mar 23, 2023 | 10%+ Owner |
| ORIC | Oric Pharmaceuticals, Inc. | Dec 23, 2022 | 0 | $0 | 3 | Dec 29, 2022 | 10%+ Owner |
| PYXS | Pyxis Oncology, Inc. | Oct 6, 2022 | 0 | $0 | 3 | Oct 13, 2022 | 10%+ Owner |